Overview Study of a 4-phasic Oral Contraceptive for the Treatment of Heavy Menstrual Bleeding Status: Completed Trial end date: 2015-06-01 Target enrollment: Participant gender: Summary To evaluate efficacy and safety of a combined oral contraceptive of estradiol valerate and dienogest in the treatment of heavy menstrual bleeding Phase: Phase 3 Details Lead Sponsor: BayerTreatments: Contraceptive AgentsContraceptives, OralDienogestEstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valeratePolyestradiol phosphate